ResearcherUniversity of California San DiegoActive in the last 2 years
Jayanth S. Shankara Narayanan
Matched on ORCID iD 0000-0002-8772-8680; OpenAlex author ID A5036697900. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 2 papers
Papers 8
- Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer - A review. First author DOI 10.1016/j.heliyon.2023.e23551↗
- Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the Tumor Microenvironment. Co-author DOI 10.1158/1535-7163.mct-23-0572↗
- Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model. First author DOI 10.1016/j.surg.2023.05.011↗
- Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metasta… Co-author DOI 10.1136/jitc-2022-006133↗
- Oxaliplatin-induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthotopic murine pancreatic cancer model. Co-author DOI 10.1007/s12672-022-00483-4↗
- Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model. Co-author DOI 10.1016/j.surg.2020.04.059↗
- Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model. Co-author DOI 10.1158/2326-6066.cir-19-0101↗
- A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation. Co-author DOI 10.3791/57265↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rebekah Ruth White · 8 shared papers, 2018–2024 · strength 1.29
- Paper Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer - A review. DOI 10.1016/j.heliyon.2023.e23551↗
- Paper Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the… DOI 10.1158/1535-7163.mct-23-0572↗
- Paper Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a m… DOI 10.1016/j.surg.2023.05.011↗
- Suna Erdem · 5 shared papers, 2020–2024 · strength 0.89
- Paper Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer - A review. DOI 10.1016/j.heliyon.2023.e23551↗
- Paper Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the… DOI 10.1158/1535-7163.mct-23-0572↗
- Paper Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic imm… DOI 10.1136/jitc-2022-006133↗
- Partha Ray · 5 shared papers, 2018–2023 · strength 0.64
- Paper Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic imm… DOI 10.1136/jitc-2022-006133↗
- Paper Oxaliplatin-induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthoto… DOI 10.1007/s12672-022-00483-4↗
- Paper A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation. DOI 10.3791/57265↗
- Diego A. Vicente · 4 shared papers, 2019–2023 · strength 0.54
- Paper Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a m… DOI 10.1016/j.surg.2023.05.011↗
- Paper Oxaliplatin-induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthoto… DOI 10.1007/s12672-022-00483-4↗
- Paper Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model. DOI 10.1016/j.surg.2020.04.059↗
- Steven C. Katz · 3 shared papers, 2020–2023 · strength 0.45
- Paper Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a m… DOI 10.1016/j.surg.2023.05.011↗
- Paper Oxaliplatin-induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthoto… DOI 10.1007/s12672-022-00483-4↗
- Paper Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model. DOI 10.1016/j.surg.2020.04.059↗
- Benedict A. Capacio · 2 shared papers, 2020–2023 · strength 0.29
- Mathias Worni · 1 shared paper, 2024 · strength 0.28
- Stephen Philip Schoenberger · 2 shared papers, 2019–2023 · strength 0.26
- Paper Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic imm… DOI 10.1136/jitc-2022-006133↗
- Paper Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Mur… DOI 10.1158/2326-6066.cir-19-0101↗
- Yuan Chen · 1 shared paper, 2024 · strength 0.19
- Jorge de la Torre Medina · 1 shared paper, 2024 · strength 0.19
- Andrew M. Lowy · 1 shared paper, 2024 · strength 0.19
- Hervé Tiriac · 1 shared paper, 2023 · strength 0.16
- Ibtehaj A. Naqvi · 1 shared paper, 2018 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.